Pillstats
Rx only · Capsule, Gelatin Coated · Oral

Lubiprostone

Brands: Amitiza · Amitza · Lubiprostone

12 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US31 NDCs
12 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers14 labelers
Packages65
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 15 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.71$3.42$5.13$6.84Feb 2025Apr 2026Jul 2026
$1.732
Latest avg · Jul 22, 2026
-71%
Since Feb 19, 2025
12
Active US suppliers
65%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

16K33K49K65K2025 Q12025 Q22025 Q32025 Q42026 Q1
49K
Rx · 2026 Q1
3.2M
Units dispensed
-9%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it12 active · 2 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Proficient Rx LPunknown33SUPPLYING
Asclemed USA, Inc.unknown8SUPPLYING
SpecGx LLCunknown4SUPPLYING
Par Health USA, LLCunknown2SUPPLYING
Golden State Medical Supply, Inc.unknown2SUPPLYING
American Health Packagingunknown2SUPPLYING
Teva Pharmaceuticals USA, Inc.unknown2SUPPLYING
Advanced Rx of Tennessee, LLCunknown2SUPPLYING
Natco Pharma Limitedunknown2SUPPLYING
Direct_Rxunknown2SUPPLYING
Dr.Reddy's laboratories Limitedunknown2SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown2SUPPLYING
Quality Care Products, LLCunknown1EXITED 2026
Takeda Pharmaceuticals America, Inc.unknown1EXITED 2027

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • May 13, 2019
    RECALLRecall (Class II): Amitiza (lubiprostone) capsules, 8 mcg, 60-count bottle, Rx only, Manufactured by: Sucampo Pharma Americas, LLC, NDC 64…

    Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue. — Recalling firm: MALLINCKRODT PHARMACEUTICALS — US Nationwide

  • May 13, 2019
    RECALLRecall (Class II): Amitiza (lubiprostone) capsules, 24 mcg, 60-count bottle, Rx only, Manufactured by: Sucampo Pharma Americas, LLC, NDC 6…

    Labeling: Label mix-up. Amitiza 8 mcg capsules are being recalled because 24 mcg capsules were found in a 8 mcg trade 60 ct. bottle. Amitiza 24 mcg capsules are being recalled because a sealed 60 ct. bottle contained only 8 mcg capsules, this incident is being considered as a labeling mix-up issue. — Recalling firm: MALLINCKRODT PHARMACEUTICALS — US Nationwide

  • Nov 6, 2018
    RECALLRecall (Class III): AMITIZA (lubiprostone) capsules 8 mcg. 60-count bottle, Rx Only. Marketed by: Sucampo Pharma Americas, LLC, Rockville M…

    Failed Impurities/Degradation Specifications:Elevated levels of a known impurity in the 20-month stability sample testing. — Recalling firm: Takeda Development Center Americas, Inc. — Product was distributed to 32 distributors throughout the United States.